Hillstar Bio - Olean Times Herald

Hillstar Bio Launches with $67 Million Series A Financing to Develop Next Wave of Precision Immunotherapies to Transform Autoimmune Treatment

Press Releases

Hillstar Bio Launches with $67 Million Series A Financing to Develop Next Wave of Precision Immunotherapies to Transform Autoimmune Treatment

Hillstar Bio

March 25, 2025

Proceeds to fund advancement of the company's lead TRBV9 program through clinical proof-of-concept study in axial spondyloarthritis and progression of...